DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 2Dr. Reddy's Laboratories
02 1Chongqing Carelife Pharmaceutical
03 1Hetero Drugs
04 2MSN Laboratories
05 2Olon S.p.A
06 1Shilpa Medicare
07 1Sun Pharmaceutical Industries Limited
Reset all filters
01 1LENVATINIB MESILATE NON STERILE BULK DRUG SUBSTANCE
02 5LENVATINIB MESYLATE
03 1LENVATINIB MESYLATE (FORM-C)
04 1LENVATINIB MESYLATE (MIBK SOLVATE)
05 1LENVATINIB MESYLATE FORM C
06 1LENVATINIB MESYLATE [ROUTE CODE JC]
Reset all filters
01 1China
02 7India
03 2Italy
Reset all filters
01 10Active
Reset all filters
01 8Complete
02 2Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2018-10-24
Pay. Date : 2018-08-09
DMF Number : 32905
Submission : 2018-06-26
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2021-11-30
Pay. Date : 2021-11-08
DMF Number : 36031
Submission : 2021-06-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-01-24
Pay. Date : 2021-12-16
DMF Number : 36197
Submission : 2021-12-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39887
Submission : 2024-04-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-03-25
Pay. Date : 2018-11-19
DMF Number : 33017
Submission : 2018-08-07
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-03-31
Pay. Date : 2023-03-17
DMF Number : 35779
Submission : 2021-03-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-11-26
Pay. Date : 2024-09-30
DMF Number : 37347
Submission : 2022-07-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33964
Submission : 2019-06-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-11-20
Pay. Date : 2018-09-04
DMF Number : 33083
Submission : 2018-09-04
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-03-27
Pay. Date : 2018-12-12
DMF Number : 33331
Submission : 2019-02-04
Status : Active
Type : II
75
PharmaCompass offers a list of Lenvatinib Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lenvatinib Mesylate manufacturer or Lenvatinib Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lenvatinib Mesylate manufacturer or Lenvatinib Mesylate supplier.
PharmaCompass also assists you with knowing the Lenvatinib Mesylate API Price utilized in the formulation of products. Lenvatinib Mesylate API Price is not always fixed or binding as the Lenvatinib Mesylate Price is obtained through a variety of data sources. The Lenvatinib Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lenvatinib Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lenvatinib Mesylate, including repackagers and relabelers. The FDA regulates Lenvatinib Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lenvatinib Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lenvatinib Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lenvatinib Mesylate supplier is an individual or a company that provides Lenvatinib Mesylate active pharmaceutical ingredient (API) or Lenvatinib Mesylate finished formulations upon request. The Lenvatinib Mesylate suppliers may include Lenvatinib Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Lenvatinib Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lenvatinib Mesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Lenvatinib Mesylate active pharmaceutical ingredient (API) in detail. Different forms of Lenvatinib Mesylate DMFs exist exist since differing nations have different regulations, such as Lenvatinib Mesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lenvatinib Mesylate DMF submitted to regulatory agencies in the US is known as a USDMF. Lenvatinib Mesylate USDMF includes data on Lenvatinib Mesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lenvatinib Mesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lenvatinib Mesylate suppliers with USDMF on PharmaCompass.
We have 7 companies offering Lenvatinib Mesylate
Get in contact with the supplier of your choice: